Rights and permissions
About this article
Cite this article
Look at a disease-specific measure to assess QOL in CAD. Pharmacoecon. Outcomes News 20, 12 (1995). https://doi.org/10.1007/BF03293686
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03293686